Abstract
Histone lysine acetylation is a key regulator of gene expression. Cancer manifests because of both genetic and epigenetic alterations. In several solid tumours and haematological malignancies the histone acetylation patterns are distorted as a result of various genetic or epigenetic changes. Reduced activity of histone lysine acetyltransferases (HATs) and/or increased
... read more